Top Glucometer Brands for Accurate Blood Sugar Monitoring

Monitoring blood glucose levels is crucial for individuals with diabetes, and selecting the right glucometer brand can make a significant difference in managing the condition effectively. With numerous options available in the market today, it can be overwhelming to determine which glucometer provides the most accurate readings and essential features tailored to individual needs. Some brands have set themselves apart by offering user-friendly devices, reliable technology, and excellent customer support. To discover our top picks and understand what each brand offers, read on below.

Illustration of glucometer

Best brands of glucometer in 2025

Accu-Chek

The Accu-Chek brand is a leading producer of glucometers, with the Accu-Chek Inform II holding the largest market share of 18.9% in 2023 in the U.S. point-of-care glucose testing market. This device is designed for in-vitro diagnostic procedures, measuring blood glucose levels in various sample types, including venous, capillary, whole blood, and neonatal & arterial samples. It is widely used by healthcare professionals as a bedside monitoring tool, automating data management and enhancing patient care. The Accu-Chek Inform II has also held a significant revenue share, with over 45.0% in 2020 globally. The brand's products are known for their advanced accuracy and user-friendly features.

OneTouch

The OneTouch brand is renowned for its high-quality glucometers, particularly the OneTouch Verio Flex, which was rated as the Best Standard Glucose Meter of 2022 by Forbes Health due to its affordable test strips, color range indicator, and compact design. This meter stands out for its ColorSure® technology, which instantly indicates if blood glucose levels are low, high, or within a personal range. OneTouch continues to be the most recommended meter brand, highlighting its reliability and user satisfaction. The brand's commitment to improving lives for people with diabetes is evident through its innovative products and comprehensive support, including the OneTouch Reveal mobile app. With over 20 years of dedication to diabetes management, OneTouch remains a leader in the point-of-care glucose testing market. For more information, visit the OneTouch website.

FreeStyle

The FreeStyle brand, led by Abbott, has revolutionized diabetes management with its innovative continuous glucose monitoring (CGM) systems, particularly the FreeStyle Libre, which is the No. 1 sensor-based glucose monitoring system worldwide, used by over 1 million people across 44 countries. The FreeStyle Libre systems, including the Libre 2 and Libre 3, offer real-time glucose monitoring without the need for fingersticks, and features such as real-time alarms for high or low glucose levels. These systems have been approved by regulators in Europe and the U.S., enhancing their global reach. The global market for CGM devices, led by FreeStyle Libre, is projected to reach $16.5 billion by 2031, growing at a CAGR of 17.8%. Abbott's FreeStyle Libre portfolio has already helped roughly 6 million people worldwide manage their diabetes.

Contour Next

The Contour Next brand, produced by Ascensia Diabetes Care, is a leading name in the glucometer market, known for its accuracy and user-friendly design. In 2023, the self-monitoring blood glucose devices segment, which includes Contour Next products, accounted for 66.37% of the market share due to their affordability and ease of use. The global blood glucose test strips market, where Contour Next strips are a significant component, is projected to grow at a CAGR of 8.1% from 2024 to 2031, reaching USD 31.45 billion by 2031. The rising prevalence of diabetes, with approximately 537 million individuals diagnosed in 2021 and a projected rise to 643 million by 2030, drives the demand for these products. Contour Next glucometers are favored for their precision and compatibility with various test strips. For more information on Contour Next products, visit their website.

ReliOn

The ReliOn brand is renowned for producing high-quality, cost-effective glucometers that meet stringent FDA requirements for accuracy. The ReliOn Premier CLASSIC Blood Glucose Meter, for example, is highly accurate and user-friendly, with a minimum sample size of 0.5 uL and a test time of just 5 seconds. It also features a memory capacity for 500 test results with time and date stamps. ReliOn meters, such as the ReliOn Prime and ReliOn Confirm (Micro), have demonstrated high accuracy rates in surveillance programs, with the ReliOn Prime showing a 92.3% accuracy rate. These features and performance metrics make ReliOn a trusted choice for individuals managing diabetes.

iHealth

iHealth is a prominent player in the glucometer market, known for its innovative and user-friendly blood glucose monitoring devices. The company's products are part of a larger market that was valued at around USD 16.3 billion in 2023 and is expected to grow at a 12.8% CAGR from 2024 to 2032. iHealth's devices, including blood glucose meters and continuous glucose monitors, cater to the increasing demand driven by the rising prevalence of diabetes, with type 2 diabetes accounting for over 92.7% of the market share in 2023. The U.S. self-monitoring blood glucose devices market, which includes iHealth, is projected to grow from USD 4,045 million in 2023 to USD 7,138 million by 2032, with a CAGR of 6.5% during the forecast period. iHealth's focus on accuracy, affordability, and accessibility aligns with the key priorities for manufacturers in this sector.

Dexcom

Dexcom is a leading producer of continuous glucose monitoring (CGM) systems, renowned for its innovative and accurate technologies. In 2023, Dexcom reported significant revenue growth of 24% over the previous year, reaching approximately $3.62 billion, and anticipates further growth of 16% to 21% in 2024, targeting $4.15 billion to $4.35 billion in revenue. The company's Dexcom G7 is recognized as the most accurate CGM available, and it has expanded to over 15 international markets. Dexcom also plans to launch its new Stelo sensor in summer 2024, aimed at people with Type 2 diabetes who do not use insulin, and expects to reach a broader market including those without diabetes. With a strong market presence, Dexcom dominates the U.S. blood glucose monitoring system market, contributing to the segment's growth at a CAGR of 9.6% from 2023 to 2030. For more information, visit Dexcom's website.

Livongo

Livongo is a leading provider in the diabetes management sector, known for its innovative glucometer and comprehensive health coaching platform. The company's partnership with Dexcom integrates continuous glucose monitoring (CGM) data, enhancing its ability to offer personalized insights and nudges to users, particularly those with Type 2 diabetes, where 10 to 20 percent of Livongo's members already use CGMs. In 2020, Livongo reported a significant revenue growth of 148 percent year-over-year, reaching $46.7 million in the third quarter, and secured its largest diabetes contract with the Blue Cross and Blue Shield Federal Employee Program, expecting to add up to 45,000 new members by 2021. Livongo's platform includes a connected meter, lancing device, and test strips, all designed for easy and accurate blood glucose monitoring. The company's focus on data analytics and AI-driven health coaching has made it a standout in the chronic care management market. For more information about Livongo's innovative health solutions, you can visit their official website.

Prodigy

Prodigy Diabetes Care is a leading producer of glucometers, notably with the Prodigy Autocode, which held a significant 26.9% market share in the Medicare mail-order market as of 2013, marking a substantial increase from 2.4% in 2009. This product is part of the self-monitoring devices segment, which dominates the global glucose monitoring market with a 57.9% value share in 2024. Prodigy's devices are known for their convenience, affordability, and accuracy, with the Prodigy Auto Code achieving a 90.3% accuracy rate in a surveillance program. The company's presence in the market is further reinforced by its inclusion among key players in the point-of-care glucose testing market, alongside other major brands like Abbott and Nova Biomedical. For more insights, you can explore the detailed analysis of the point-of-care glucose testing market.

True Metrix

The True Metrix brand, part of Trividia Health, is renowned for its highly accurate and cost-effective blood glucose monitoring solutions. The True Metrix Meter utilizes Triple Sense Technology, ensuring clinically proven accuracy that exceeds ISO standards, with 99% of results from healthcare professionals falling within the defined accuracy limits. This technology detects, analyzes, and corrects variables in each blood sample, providing reliable readings in as fast as 4 seconds with a tiny 0.5 microliter sample size. The meter also offers features like alternate site testing, storage of 500 results, and download capabilities. Additionally, Trividia Health's test strips and lancets are covered under most U.S. insurance plans, including Medicare and Medicaid, significantly reducing patients' out-of-pocket expenses.